PHILADELPHIA, March 25, 2014 /PRNewswire/ -- Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat ...
Spark Therapeutics, a spinout of Children’s Hospital of Philadelphia, will team up with Genable Technologies to develop Genable’s lead therapeutic GT038, a gene therapy designed to treat ...
Dublin, 7th March 2016 – Genable, an Irish bio-pharmaceutical company developing novel gene therapies for the treatment of dominant genetic diseases, today announced that it has completed a ...
Dublin-based biopharmaceutical company Genable Technologies has secured the worldwide licence to Benitec Biopharma’s ddRNAi technology, in a move the company believes will help progress the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results